Extracorporeal Membrane Oxygenation
Also known as: Extracorporeal Membrane Oxygenation Support / ExtraCorporeal Membrane Oxygenation (ECMO) / Extra Corporeal Membrane Oxygenation / ECMO Treatment / Extracorporeal membrane oxygenation (procedure) / Lung assist device therapy
Drug | Drug Name | Drug Description |
---|---|---|
DB11817 | Baricitinib | A Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist. |
DB14761 | Remdesivir | A nucleoside analog used to treat RNA virus infections including COVID-19. |
DB06273 | Tocilizumab | An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB15127 | Hydrogen | 1 | Recruiting | 1 |
DB00770 | Alprostadil | 2 | Terminated | 1 |
DB00327 | Hydromorphone | 2 | Recruiting | 1 |
DB09153 | Sodium chloride | 2 | Terminated | 1 |
DB01109 | Heparin | 3 | Recruiting | 1 |
DB08813 | Nadroparin | 3 | Recruiting | 1 |
DB00512 | Vancomycin | 4 | Completed | 1 |
DB00435 | Nitric Oxide | Not Available | Unknown Status | 1 |